Updated Aug. 13, 2014 at 12:10 p.m.

Premium Lock RTP drug firm BioCryst receives $4.1M in federal funds for Ebola vaccine

Published: 2014-08-13 10:22:00
Updated: 2014-08-13 12:10:37

Ebola fight   In this photo taken Saturday, Aug. 9, 2014, health worker wearing protective clothing and equipment, out of fear for the deadly Ebola virus, sit at a desk at the Kenema Government Hospital situated in the Eastern Province in Kenema, 300 kilometers, (186 miles) from the capital city of Freetown, Sierra Leone. Over the decades, Ebola cases have been confirmed in 10 African countries, including Congo where the disease was first reported in 1976. But until this year, Ebola had never come to West Africa. (AP Photo/ Michael Duff) Image 1 of 2 · Next Image…

The National Institute of Allergy and Infectious Diseases has provided another $4.1 million in funding to Triangle-based BioCryst Pharmaceuticals for further development of a potential vaccine to treat Ebola....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll